Roche
Roche cancer drug Tarceva set for first-line licence
July 25, 2011Sales and Marketing Cancer, Roche, Tarceva
Roche’s cancer drug Tarceva is on course to win a first-line indication in Europe for the first time after regulatory …
Merck and Roche extend Victrelis co-promotion deal to Europe
July 22, 2011Sales and Marketing Merck & Co, Roche, Victrelis, hepatitis C
Merck & Co is ramping up efforts to push its new hepatitis C treatment Victrelis to the fore, signing a …
Roche and Evotec to collaborate on cancer biomarkers
June 24, 2011Research and Development Evotec, Roche, biomarkers
Roche and Evotec are to collaborate to find biomarkers for Roche oncology drugs under development. Roche has been one of …
Roche launches R&D Institute in France
June 24, 2011Research and Development Roche, translational research
Roche has launched a new R&D Institute in France, furthering its links with academic centres in the country. The Institute, …
Mid-stage trial boost for Roche skin cancer drug vismodegib
June 20, 2011Research and Development Cancer, Roche, skin cancer, vismodegib
Roche’s novel skin cancer drug vismodegib has met its primary endpoint in a phase II trial. Vismodegib is an investigational, …
Roche and Merck collaborate on personalised cancer tests
June 8, 2011Research and Development Merck, Roche, personalised medicine
Roche has signed a deal to develop diagnostic tests for products in Merck’s oncology pipeline, in a bid to make …
Roche impresses at ASCO with vemurafenib
June 6, 2011Research and Development, Sales and Marketing ASCO, Roche, skin cancer, vemurafenib
Roche’s vemurafenib has proven one of the stars of the ASCO cancer conference by increasing overall survival in skin cancer …
BMS and Roche to team up in melanoma
June 3, 2011Sales and Marketing BMS, Roche, melanoma, oncology
Bristol-Myers Squibb and Roche are to use two of their drugs in an exploratory phase I/II study a bid to …
Tarceva impresses again as it seeks to extend its EU licence
June 3, 2011NSCLC, Roche, Tarceva
Roche and its partner OSI Pharmaceuticals have released another series of positive results for its lung cancer drug Tarceva as …
Digital Pharma: Roche launches online warfarin training for patients
May 27, 2011Medical Communications Digital Pharma blog, Roche, anticoagulant, warfarin
Roche has launched an online training tool to help UK patients on long-term warfarin learn about anticoagulation self-monitoring. The CoaguChek …
NICE U-turn on Roche’s MabThera
May 25, 2011Sales and Marketing MabThera, NICE, Roche
NICE has provisionally recommended Roche’s MabThera as a maintenance therapy for blood cancer patients. The new draft guidance backs MabThera’s …
MetMab produces exciting results in lung cancer patients
May 19, 2011Research and Development MetMAb, Roche
Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …
Merck and Roche sign hepatitis C co-promotion deal
May 18, 2011Medical Communications, Sales and Marketing Merck, Roche, hepatitis C
Merck & Co and Roche have signed an agreement that will see them co-promote each other’s hepatitis C drugs in …
Roche aims for wholly personalised skin cancer drug
May 12, 2011Sales and Marketing Roche, personalised medicine, skin cancer, vemurafenib
Roche has submitted its key skin cancer drug vemurafenib to European and American regulators for approval. Vemurafenib (formerly RG7204) has …
Roche growth stalls after Avastin setback
April 14, 2011Research and Development, Sales and Marketing Roche
Revenues at Roche flattened out in the first three months of 2011, as Avastin sales declined in the US and Europe. Group …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
